Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Olba DVx HealthcareTSE:2689 62 Earnings Yield (Joel Greenblatt) % is 15.93% as of Jun. 2026, which is 8% above its 10-year median of 14.78. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,164.82 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 126 Medical Distribution companies, Olba DVx Healthcare ranks better than 82.54% on this metric.
Olba DVx Healthcare's Enterprise Value for the quarter that ended in Jun. 2026 was 円11,519 Mil.
Olba DVx Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was 円1,835 Mil. Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 15.93%.
The historical rank and industry rank for Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
TSE:2689'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.56 Med: 14.78 Max: 32.86
Current: 15.73
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Olba DVx Healthcare was 32.86%. The lowest was 4.56%. And the median was 14.78%.
TSE:2689's Earnings Yield (Joel Greenblatt) % is ranked better than 82.54% of 126
companies
in the Medical Distribution industry
Industry Median: 5.965
vs TSE:2689: 15.73
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Olba DVx Healthcare's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 4.06%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Olba DVx Healthcare Earnings Yield (Joel Greenblatt) % Related Terms
Olba DVx Healthcare Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olba DVx Healthcare Earnings Yield (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Olba DVx Healthcares Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jun. 2026 is calculated as
Olba DVx Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,835 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 15.93% mean?
Olba DVx Healthcare (TSE:2689) has a Earnings Yield (Joel Greenblatt) % of 15.93% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Olba DVx Healthcare and its competitors. This is near median its historical median of 14.78. Over the past decade, Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) % has ranged from 4.56 to 32.86. According to the industry distribution chart, Olba DVx Healthcare ranks #22 out of 126 companies in the Medical Distribution industry, placing it in the top 17.5%.
Is Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) % too high?
Olba DVx Healthcare's current Earnings Yield (Joel Greenblatt) % of 15.93% is near median its 10-year median of 14.78. Over the past 10 years, this metric has ranged from a low of 4.56 to a high of 32.86. The Medical Distribution industry median Earnings Yield (Joel Greenblatt) % is 5.97. Olba DVx Healthcare's value of 15.93% is 167.1% above this industry median. Based on the distribution chart, Olba DVx Healthcare ranks #22 out of 126 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's Earnings Yield (Joel Greenblatt) % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Olba DVx Healthcare ranks #22 out of 126 companies for Earnings Yield (Joel Greenblatt) %. This places Olba DVx Healthcare in the top 18% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 5.97. Olba DVx Healthcare's value of 15.93% is 167.1% above this benchmark. Historically, Olba DVx Healthcare's own Earnings Yield (Joel Greenblatt) % has ranged from 4.56 to 32.86 over the past decade. While the company's 10-year median is 14.78 vs. the industry median of 5.97, Olba DVx Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Distribution company?
The median Earnings Yield (Joel Greenblatt) % among Medical Distribution companies is 5.97, based on 126 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current Earnings Yield (Joel Greenblatt) % of 15.93% is 167.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Olba DVx Healthcare and its competitors. For the Medical Distribution industry, the median Earnings Yield (Joel Greenblatt) % is 5.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current Earnings Yield (Joel Greenblatt) % is 15.93%, which is near median its own 10-year median of 14.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.82, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 15.93%, which is near median its 10-year median of 14.78 and 167.1% above the Medical Distribution industry median of 5.97. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current Earnings Yield (Joel Greenblatt) % is 15.93% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?
Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued.
The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.82.
GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.
Key valuation signals for TSE:2689:
Earnings Yield (Joel Greenblatt) %: 15.93% (near median its 10-year median of 14.78)
GF Value™: 円2,164.82 vs. price of 円1,925.00 (11.1% below fair value)
Industry Position: 167.1% above the Medical Distribution median (#22 of 126)
No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score
Get the complete analysis for TSE:2689
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2689 has been successfully added to your 
